Largest Biotechnology Industry Companies
There are 646 Biotechnology companies.
All industries.
Total Market Cap: $1.19T
Rank | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (646 stocks) | +8.47% | 20.86 | 15.98 | 0.26 | -1.98% | 5.01% | +57.19% | +10.82% | 0.90 | |||||
1 | VRTX | Vertex Pharmaceuticals Inc | $445.04 | $111B | +9.89% | 25.57 | 23.47 | 1.68 | 3.35% | N/A | 74 | +23.29% | $549 | +18.18% | 0.51 |
2 | VRNA | Verona Pharma Plc | $106.91 | $78B | N/A | N/A | N/A | N/A | -0.09% | N/A | N/A | N/A | N/A | +71.15% | N/A |
3 | REGN | Regeneron Pharmaceuticals Inc | $611.48 | $63B | +20.31% | 14.36 | 13.74 | 79.72 | 8.01% | 0.59% | 72 | +36.28% | $833 | +3.24% | 0.63 |
4 | ARGX | Argen X SE | $898.94 | $57B | N/A | 24.24 | 33.44 | 0.21 | 1.73% | N/A | 78 | +14.17% | $1.03K | +23.36% | 0.46 |
5 | ALNY | Alnylam Pharmaceuticals Inc | $289.39 | $39B | N/A | 123.07 | 31.85 | 0.51 | 1.21% | N/A | 74 | +52.50% | $441 | +11.89% | 0.80 |
6 | ONC | BeiGene Ltd | $260.27 | $31B | N/A | 58.89 | 43.48 | N/A | 2.77% | N/A | 81 | +58.43% | $412 | -5.58% | 0.52 |
7 | RVMD | Revolution Medicines Inc | $149.23 | $29B | +30.12% | N/A | N/A | N/A | -3.71% | N/A | 78 | +25.50% | $187 | +34.21% | 1.08 |
8 | RPRX | Royalty Pharma plc - Class A | $55.29 | $24B | N/A | 27.78 | 45.87 | 1.28 | 10.97% | 1.63% | 80 | +7.16% | $59 | +6.72% | 0.27 |
9 | BNTX | BioNTech SE | $89.54 | $22B | N/A | N/A | 7.04 | N/A | 0.72% | N/A | 69 | +37.27% | $123 | -17.42% | 0.95 |
10 | INCY | Incyte Corp | $107.83 | $21B | +27.16% | 14.49 | 13.40 | N/A | 7.20% | N/A | 58 | +0.93% | $109 | +5.48% | 0.59 |
11 | ROIV | Roivant Sciences Ltd | $29.73 | $21B | N/A | N/A | N/A | N/A | -3.75% | N/A | 76 | +31.32% | $39 | 0.00% | 0.93 |
12 | INSM | Insmed Inc | $96.72 | $20B | +12.24% | N/A | 16.37 | 1.09 | -4.63% | N/A | 80 | +104.82% | $198 | +26.33% | 0.81 |
13 | MRNA | Moderna Inc | $49.64 | $18B | N/A | N/A | 23.04 | N/A | -8.78% | N/A | 48 | -12.77% | $43 | -25.67% | 1.40 |
14 | GMAB | Genmab | $25.24 | $16B | -30.81% | 118.15 | 14.37 | 1.62 | 0.88% | N/A | 70 | +45.88% | $37 | -10.41% | 0.62 |
15 | JAZZ | Jazz Pharmaceuticals plc | $236.17 | $14B | N/A | N/A | 12.52 | 0.96 | 8.93% | N/A | 78 | +7.80% | $255 | +4.87% | 0.72 |
16 | ASND | Ascendis Pharma A/S | $215.60 | $14B | N/A | 23.50 | 12.11 | N/A | 0.37% | N/A | 80 | +37.48% | $296 | +10.60% | 0.47 |
17 | EXEL | Exelixis Inc | $53.50 | $13B | +72.24% | 16.60 | 16.64 | 0.43 | 6.88% | N/A | 61 | -8.41% | $49 | +18.41% | 0.53 |
18 | BBIO | BridgeBio Pharma Inc | $67.55 | $13B | -3.14% | N/A | N/A | N/A | -3.37% | N/A | 79 | +52.05% | $103 | +1.11% | 1.05 |
19 | AXSM | Axsome Therapeutics Inc | $253.77 | $13B | +6.89% | N/A | 333.33 | N/A | -0.56% | N/A | 77 | +6.51% | $270 | +30.76% | 0.66 |
20 | IONS | Ionis Pharmaceuticals Inc | $73.82 | $12B | -21.44% | N/A | 90.91 | N/A | -7.98% | N/A | 78 | +36.71% | $101 | +14.25% | 0.73 |
21 | MDGL | Madrigal Pharmaceuticals Inc | $474.28 | $11B | +23.26% | N/A | 666.67 | N/A | -2.52% | N/A | 73 | +43.23% | $679 | +34.45% | 0.73 |
22 | BMRN | Biomarin Pharmaceutical Inc | $55.54 | $11B | -20.33% | 40.22 | 11.63 | 0.71 | 7.07% | N/A | 75 | +58.17% | $88 | -7.51% | 0.68 |
23 | SMMT | Summit Therapeutics Inc | $13.08 | $10B | N/A | N/A | 3.72 | N/A | -3.80% | N/A | 60 | +118.04% | $29 | +13.91% | 1.76 |
24 | ARWR | Arrowhead Pharmaceuticals Inc | $74.41 | $9.94B | +15.23% | N/A | 97.09 | N/A | -0.51% | N/A | 78 | +18.49% | $88 | -3.45% | 1.65 |
25 | NUVL | Nuvalent Inc - Class A | $123.45 | $9.70B | N/A | N/A | N/A | N/A | -3.22% | N/A | 80 | +5.94% | $131 | 0.00% | 0.99 |
26 | KRYS | Krystal Biotech Inc | $321.55 | $9.20B | N/A | 40.45 | 45.05 | 0.51 | 2.58% | N/A | N/A | N/A | N/A | +37.66% | N/A |
27 | HALO | Halozyme Therapeutics Inc | $70.73 | $8.36B | +20.06% | 23.83 | 9.90 | N/A | 7.99% | N/A | 67 | +18.62% | $84 | +10.57% | 0.62 |
28 | CYTK | Cytokinetics Inc | $69.27 | $8.27B | +27.73% | N/A | 117.65 | N/A | -6.64% | N/A | 79 | +51.15% | $105 | +26.91% | 0.76 |
29 | TECH | Bio-Techne Corp | $54.02 | $8.22B | -10.07% | 74.88 | 26.67 | 0.75 | 3.28% | 0.61% | 71 | +13.70% | $61 | -13.00% | 1.13 |
30 | CORT | Corcept Therapeutics Inc | $83.25 | $8.16B | -8.23% | 185.65 | 89.29 | 0.81 | 1.47% | N/A | 75 | +5.71% | $88 | +31.06% | 1.32 |
31 | ABVX | Abivax | $100.87 | $7.77B | +25.56% | N/A | N/A | N/A | -3.92% | N/A | 84 | +47.80% | $149 | 0.00% | 1.82 |
32 | MTSR | Metsera Inc | $70.50 | $7.40B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
33 | IBRX | ImmunityBio Inc | $7.20 | $7.31B | -9.78% | N/A | N/A | N/A | -4.09% | N/A | 83 | +80.56% | $13 | -13.87% | 1.61 |
34 | TGTX | TG Therapeutics Inc | $48.05 | $7.14B | N/A | 15.67 | 33.33 | 0.01 | -0.20% | N/A | 66 | -0.10% | $48 | +4.93% | 0.81 |
35 | MRUS | Merus N.V | $90 | $6.83B | +12.68% | N/A | N/A | N/A | -4.66% | N/A | N/A | N/A | N/A | +31.21% | N/A |
36 | PTGX | Protagonist Therapeutics Inc | $109.79 | $6.79B | +1.43% | N/A | 22.42 | N/A | -1.74% | N/A | 78 | +8.11% | $119 | +22.60% | 0.24 |
37 | PRAX | Praxis Precision Medicines Inc | $247.98 | $6.70B | -18.18% | N/A | N/A | N/A | -4.21% | N/A | 73 | +153.08% | $628 | -3.80% | 0.91 |
38 | ACLX | Arcellx Inc | $115.07 | $6.67B | N/A | N/A | 61.73 | N/A | -3.19% | N/A | N/A | N/A | N/A | 0.00% | N/A |
39 | PCVX | Vaxcyte Inc | $47.29 | $6.55B | +33.90% | N/A | N/A | N/A | -11.90% | N/A | 75 | +130.49% | $109 | +16.53% | 0.74 |
40 | CDTX | Cidara Therapeutics Inc | $221.38 | $6.49B | N/A | N/A | 5.75 | N/A | -2.05% | N/A | N/A | N/A | N/A | +38.65% | N/A |
41 | LEGN | Legend Biotech Corp | $36.28 | $6.44B | -13.49% | N/A | 232.56 | N/A | -3.67% | N/A | 80 | +58.74% | $58 | -1.88% | 0.53 |
42 | KYMR | Kymera Therapeutics Inc | $82.96 | $6.43B | N/A | N/A | N/A | N/A | -3.80% | N/A | 79 | +42.90% | $119 | +10.42% | 1.52 |
43 | IMVT | Immunovant Inc | $32.88 | $6.36B | +18.52% | N/A | N/A | N/A | -6.41% | N/A | 70 | +39.17% | $46 | +25.15% | 1.26 |
44 | APGE | Apogee Therapeutics Inc | $89.50 | $6.19B | N/A | N/A | N/A | N/A | -3.80% | N/A | 69 | +33.23% | $119 | 0.00% | 1.32 |
45 | CNTA | Centessa Pharmaceuticals plc | $39.77 | $6.14B | N/A | N/A | N/A | N/A | -3.41% | N/A | 59 | +12.07% | $45 | +12.87% | 1.10 |
46 | PTCT | PTC Therapeutics Inc | $74.71 | $6.08B | -16.59% | N/A | 51.28 | 0.81 | -3.72% | N/A | 73 | +25.73% | $94 | +11.71% | 1.03 |
47 | TERN | Terns Pharmaceuticals Inc | $52.95 | $5.95B | N/A | N/A | N/A | N/A | -1.38% | N/A | N/A | N/A | N/A | +24.90% | N/A |
48 | SYRE | Spyre Therapeutics Inc | $80.77 | $5.92B | -2.15% | N/A | N/A | N/A | -3.14% | N/A | 75 | +18.94% | $96 | -13.31% | 1.75 |
49 | RYTM | Rhythm Pharmaceuticals Inc | $87.66 | $5.87B | +17.00% | N/A | N/A | N/A | -2.05% | N/A | 79 | +57.65% | $138 | +35.66% | 0.93 |
50 | MIRM | Mirum Pharmaceuticals Inc | $99.54 | $5.73B | -34.51% | N/A | 2000.00 | N/A | -3.01% | N/A | 82 | +44.88% | $144 | +41.69% | 0.89 |